Researchers Push For Kinder, Gentler Gene Patent Protection Scheme
This article was originally published in The Gray Sheet
Executive Summary
A biotech research group that advocates a less zealous approach to gene and protein patent protection recently took its case to Capitol Hill, arguing that innovation in development of new biotech diagnostics and medicines is being stifled by fear of patent lawsuits